- Joined
- Jan 29, 2017
- Messages
- 12
- Reaction score
- 48
Hi folks,
Quick physiological question(s) for you guys. If I'm understanding it correctly, is the recommendation to use neostigmine/atropine rather than neostigmine/glycopyrrolate in pregnancy based on the concept that placental transfer of neostigmine is more extensive than that of glycopyrrolate, and thus using atropine (which more readily crosses placenta than glyco) can ameliorate any bradycardia induced by neostigmine?
Also, out in practice, are you guys routinely using neostigmine/atropine to reverse neuromuscular blockade in pregnant patients that may require GA? Do any of you continue to use suggammadex despite the theoretical antagonism with progesterone?
I tried to look up evidence for these, but didn't find anything too convincing one way or the other and wanted to see what you experienced folks are doing out in practice. At my training institution, our attendings had widely varying opinions on the topic.
Quick physiological question(s) for you guys. If I'm understanding it correctly, is the recommendation to use neostigmine/atropine rather than neostigmine/glycopyrrolate in pregnancy based on the concept that placental transfer of neostigmine is more extensive than that of glycopyrrolate, and thus using atropine (which more readily crosses placenta than glyco) can ameliorate any bradycardia induced by neostigmine?
Also, out in practice, are you guys routinely using neostigmine/atropine to reverse neuromuscular blockade in pregnant patients that may require GA? Do any of you continue to use suggammadex despite the theoretical antagonism with progesterone?
I tried to look up evidence for these, but didn't find anything too convincing one way or the other and wanted to see what you experienced folks are doing out in practice. At my training institution, our attendings had widely varying opinions on the topic.
Last edited: